Spectraline
Payments companies reported to CMS as associated with Spectraline. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Spectraline, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Spectraline
These are the largest totals companies reported as associated with Spectraline. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sandeep Sharma | Cincinnati, OH | Vascular & Interventional Radiology | $23.68 |
| Allison Ho | Minneapolis, MN | Vascular Neurology | $23.68 |
| Matthew Brogan | Minneapolis, MN | Physician Assistant | $23.68 |
| Michael Rosenberg | Minneapolis, MN | Vascular & Interventional Radiology | $23.68 |
| Ashley Beckett | Louisville, KY | Pediatrics, Critical Care | $19.27 |
| Edward Kim | Louisville, KY | Pediatric Cardiology | $19.27 |
| Jordan Evans | Fort Collins, CO | Nephrology (Internal Medicine) | $15.88 |
| Stephen Strand | Orosi, CA | Physician Assistant | $15.88 |
| Nathaniel Carman | Jbsa Ft Sam Houston, TX | Cardiovascular Disease | $15.88 |
| Benny Guzman | Chino Hills, CA | Family Medicine | $15.88 |
Prescribed Spectraline?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.